Paxil Associated with Increase in Congenital Heart Defects
Drug Company Study Associates Paxil With Increase In Congenital Heart Defects
The Food and Drug Administration is warning that the antidepressant drug Paxil may be associated with increases in birth defects. A study by GlaxoSmith Kine has found increased numbers of babies born with birth defects to women who were taking Paxil during the first trimester of pregnancy. The most significant risk was for congenital heart defects. The FDA released a letter from the manufacturer on Tuesday with a warning to health care professionals about the new study results. : http://www.fda.gov/
The Food and Drug Administration is warning that the antidepressant drug Paxil may be associated with increases in birth defects. A study by GlaxoSmith Kine has found increased numbers of babies born with birth defects to women who were taking Paxil during the first trimester of pregnancy. The most significant risk was for congenital heart defects. The FDA released a letter from the manufacturer on Tuesday with a warning to health care professionals about the new study results. : http://www.fda.gov/
posted by Birth Defect Research for Children @ 8:53 AM
1 Comments:
At August 9, 2007 at 10:37 AM,
Unknown said…
Recently there have been reports of Paxil not increasing the risk of birth defects; however, the number of first-hand accounts would suggest otherwise. I would like to share an internet resource that provides information on Paxil birth defects.
Post a Comment
<< Home